⌘K

Login Start Free

Home/Filings/4/0001731122-25-000515

4//SEC Filing

Thomas Steffen 4

Accession 0001731122-25-000515

CIK 0001314052other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 9:45 PM ET

Size

5.3 KB

Accession

0001731122-25-000515

Insider Transaction Report

Form 4

Period: 2025-03-31

ANAVEX LIFE SCIENCES CORP.AVXL

Director

Transactions

Award
Stock Option (Right to Buy)
2025-03-31+50,000→ 50,000 total
Exercise: $8.58Exp: 2035-03-31→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments beginning on March 31, 2026

Documents

1 file

4
ownership.xmlPrimary

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1

filerCIK 0001646396

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 9:45 PM ET
Size: 5.3 KB

View on SEC.gov